Advertisement
Screener

PRA Health Sciences, Inc. Capital Expenditures

PRA Health Sciences, Inc. Capital Expenditures

PRA Health Sciences, Inc. reported Capital Expenditures of $18.73 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-04-29.

Discontinued › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2021-04-29

  • PRA Health Sciences, Inc. payments to acquire property, plant, and equipment for the quarter ending 2021-03-31 was $18.73M, a 12.70% decline year-over-year.
  • PRA Health Sciences, Inc. payments to acquire property, plant, and equipment for the quarter ending 2020-12-31 was $12.78M, a 2.29% decline year-over-year.
  • PRA Health Sciences, Inc. payments to acquire property, plant, and equipment for the quarter ending 2020-09-30 was $15.15M, a 25.52% decline year-over-year.
  • PRA Health Sciences, Inc. payments to acquire property, plant, and equipment for the quarter ending 2020-06-30 was $17.41M, a 16.97% decline year-over-year.
  • PRA Health Sciences, Inc. payments to acquire property, plant, and equipment for fiscal 2020 was $66.81M, a 10.08% decline from fiscal 2019.
  • PRA Health Sciences, Inc. payments to acquire property, plant, and equipment for fiscal 2019 was $74.29M, a 32.95% increase from fiscal 2018.
  • PRA Health Sciences, Inc. payments to acquire property, plant, and equipment for fiscal 2018 was $55.88M, a 8.87% decline from fiscal 2017.
  • PRA Health Sciences, Inc. payments to acquire property, plant, and equipment for fiscal 2017 was $61.32M, a 85.01% increase from fiscal 2016.
Period endPayments to Acquire Property, Plant, and Equipment 3 monthPayments to Acquire Property, Plant, and Equipment 6 monthPayments to Acquire Property, Plant, and Equipment 9 monthPayments to Acquire Property, Plant, and Equipment 12 month
2021-03-31$18.73M
10-Q · filed 2021-04-29
$31.52M
derived: sum of 2 quarters · filed 2021-04-29
$46.67M
derived: sum of 3 quarters · filed 2021-04-29
$64.08M
derived: sum of 4 quarters · filed 2021-04-29
2020-12-31$12.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24
$27.94M
derived: sum of 2 quarters · filed 2021-02-24
$45.35M
derived: sum of 3 quarters · filed 2021-02-24
$66.81M
10-K · filed 2021-02-24
2020-09-30$15.15M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$32.56M
derived: sum of 2 quarters · filed 2020-11-05
$54.02M
10-Q · filed 2020-11-05
$67.11M
derived: sum of 4 quarters · filed 2021-04-29
2020-06-30$17.41M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07
$38.87M
10-Q · filed 2020-08-07
$51.95M
derived: sum of 3 quarters · filed 2021-04-29
$72.30M
derived: sum of 4 quarters · filed 2021-04-29
2020-03-31$21.46M
10-Q · filed 2021-04-29
$34.54M
derived: sum of 2 quarters · filed 2021-04-29
$54.89M
derived: sum of 3 quarters · filed 2021-04-29
$75.86M
derived: sum of 4 quarters · filed 2021-04-29
2019-12-31$13.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24
$33.43M
derived: sum of 2 quarters · filed 2021-02-24
$54.40M
derived: sum of 3 quarters · filed 2021-02-24
$74.29M
10-K · filed 2021-02-24
2019-09-30$20.34M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$41.31M
derived: sum of 2 quarters · filed 2020-11-05
$61.21M
10-Q · filed 2020-11-05
$77.00M
derived: sum of 4 quarters · filed 2021-02-24
2019-06-30$20.97M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07
$40.87M
10-Q · filed 2020-08-07
$56.66M
derived: sum of 3 quarters · filed 2021-02-24
$70.23M
derived: sum of 4 quarters · filed 2021-02-24
2019-03-31$19.89M
10-Q · filed 2020-05-01
$35.69M
derived: sum of 2 quarters · filed 2021-02-24
$49.27M
derived: sum of 3 quarters · filed 2021-02-24
$61.96M
derived: sum of 4 quarters · filed 2021-02-24
2018-12-31$15.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24
$29.37M
derived: sum of 2 quarters · filed 2021-02-24
$42.07M
derived: sum of 3 quarters · filed 2021-02-24
$55.88M
10-K · filed 2021-02-24
2018-09-30$13.58M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31
$26.27M
derived: sum of 2 quarters · filed 2019-10-31
$40.09M
10-Q · filed 2019-10-31
$62.12M
derived: sum of 4 quarters · filed 2020-02-21
2018-06-30$12.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01
$26.51M
10-Q · filed 2019-08-01
$48.54M
derived: sum of 3 quarters · filed 2020-02-21
$65.85M
derived: sum of 4 quarters · filed 2020-02-21
2018-03-31$13.81M
10-Q · filed 2019-05-02
$35.84M
derived: sum of 2 quarters · filed 2020-02-21
$53.15M
derived: sum of 3 quarters · filed 2020-02-21
$67.16M
derived: sum of 4 quarters · filed 2020-02-21
2017-12-31$22.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21
$39.34M
derived: sum of 2 quarters · filed 2020-02-21
$53.35M
derived: sum of 3 quarters · filed 2020-02-21
$61.32M
10-K · filed 2020-02-21
2017-09-30$17.31M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
$31.32M
derived: sum of 2 quarters · filed 2018-11-06
$39.29M
10-Q · filed 2018-11-06
$46.77M
derived: sum of 4 quarters · filed 2019-02-28
2017-06-30$14.01M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02
$21.98M
10-Q · filed 2018-08-02
$29.46M
derived: sum of 3 quarters · filed 2019-02-28
$37.58M
derived: sum of 4 quarters · filed 2019-02-28
2017-03-31$7.97M
10-Q · filed 2018-04-26
$15.46M
derived: sum of 2 quarters · filed 2019-02-28
$23.57M
derived: sum of 3 quarters · filed 2019-02-28
$32.98M
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31$7.49M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$15.60M
derived: sum of 2 quarters · filed 2019-02-28
$25.00M
derived: sum of 3 quarters · filed 2019-02-28
$33.14M
10-K · filed 2019-02-28
2016-09-30$8.11M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26
$17.52M
derived: sum of 2 quarters · filed 2017-10-26
$25.66M
10-Q · filed 2017-10-26
$32.44M
derived: sum of 4 quarters · filed 2018-02-22
2016-06-30$9.41M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08
$17.55M
10-Q · filed 2017-08-08
$24.32M
derived: sum of 3 quarters · filed 2018-02-22
$33.29M
derived: sum of 4 quarters · filed 2018-02-22
2016-03-31$8.14M
10-Q · filed 2017-04-26
$14.92M
derived: sum of 2 quarters · filed 2018-02-22
$23.89M
derived: sum of 3 quarters · filed 2018-02-22
$33.34M
derived: sum of 4 quarters · filed 2018-02-22
2015-12-31$6.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22
$15.75M
derived: sum of 2 quarters · filed 2018-02-22
$25.20M
derived: sum of 3 quarters · filed 2018-02-22
$32.81M
10-K · filed 2018-02-22
2015-09-30$8.97M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
$18.43M
derived: sum of 2 quarters · filed 2016-11-03
$26.04M
10-Q · filed 2016-11-03
$34.37M
derived: sum of 4 quarters · filed 2017-02-23
2015-06-30$9.46M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29
$17.07M
10-Q · filed 2016-07-29
$25.40M
derived: sum of 3 quarters · filed 2017-02-23
$32.51M
derived: sum of 4 quarters · filed 2017-02-23
2015-03-31$7.61M
10-Q · filed 2016-04-28
$15.94M
derived: sum of 2 quarters · filed 2017-02-23
$23.06M
derived: sum of 3 quarters · filed 2017-02-23
$29.15M
derived: sum of 4 quarters · filed 2017-02-23
2014-12-31$8.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23
$15.45M
derived: sum of 2 quarters · filed 2017-02-23
$21.54M
derived: sum of 3 quarters · filed 2017-02-23
$27.32M
10-K · filed 2017-02-23
2014-09-30$7.12M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03
$13.21M
derived: sum of 2 quarters · filed 2015-11-03
$18.99M
10-Q · filed 2015-11-03
$23.90M
derived: sum of 4 quarters · filed 2016-02-25
2014-06-30$6.09M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-28
$11.88M
10-Q · filed 2015-07-28
$16.79M
derived: sum of 3 quarters · filed 2016-02-25
2014-03-31$5.78M
10-Q · filed 2015-05-07
$10.69M
derived: sum of 2 quarters · filed 2016-02-25
2013-12-31$4.91M
10-K · filed 2016-02-25